1,340 results on '"A, Braun"'
Search Results
2. Gasdermin D drives focal crystalline thrombotic microangiopathy by accelerating immunothrombosis and necroinflammation
3. Procoagulant platelets promote immune evasion in triple-negative breast cancer
4. Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development
5. A phase 2 trial of CD24Fc for prevention of graft-versus-host disease
6. Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
7. Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms
8. Peripheral B cells repress B-cell regeneration in aging through a TNF-α/IGFBP-1/IGF-1 immune-endocrine axis
9. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy
10. Cytokine-like protein 1–induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML
11. Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study
12. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity
13. Noncanonical effector functions of the T-memory–like T-PLL cell are shaped by cooperative TCL1A and TCR signaling
14. Platelets docking to VWF prevent leaks during leukocyte extravasation by stimulating Tie-2
15. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell–derived galectin-3
16. Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
17. α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
18. Gemtuzumab Ozogamicin for Patients with Newly Diagnosed CD33 Positive Acute Myeloid Leukemia: Results from a French Retrospective Observational Study
19. Cytoprotective activated protein C averts Nlrp3 inflammasome–induced ischemia-reperfusion injury via mTORC1 inhibition
20. Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT
21. Twinfilin 2a regulates platelet reactivity and turnover in mice
22. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia
23. FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation
24. Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic Gvhd and Candidate GVL Targets
25. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia
26. GALE force in platelet production
27. An unexpected partnership targeting FLT3wt AML
28. Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup
29. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
30. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis
31. Pre-Clinical Investigation of a Novel Small Molecule Inhibitor Targeting YBX1 in AML
32. Initial Efficacy and Safety of Acalabrutinib Plus RICE in Transplant Eligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
33. Olutasidenib (FT-2102) Induces Durable Complete Remissions in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia. Results from a Planned Interim Analysis of a Phase 2 Pivotal Clinical Trial
34. Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma. Iskpd - IFM2018-03
35. Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic Gvhd and Candidate GVL Targets
36. Prognostic Impact of Monoallelic Versus Biallelic TP53 Alterations in Intensively-Treated Adults AML Patients: A Retrospective Study from the ALFA Group
37. Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality
38. Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor–induced interleukin 12 synthesis
39. Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
40. Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100
41. EGFL7 ligates αvβ3 integrin to enhance vessel formation
42. GALE force in platelet production
43. An unexpected partnership targeting FLT3wt AML
44. Targeting oncogenic Ras signaling in hematologic malignancies
45. Initial Efficacy and Safety of Acalabrutinib Plus RICE in Transplant Eligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
46. Pre-Clinical Investigation of a Novel Small Molecule Inhibitor Targeting YBX1 in AML
47. Prognostic Impact of Monoallelic Versus Biallelic TP53 Alterations in Intensively-Treated Adults AML Patients: A Retrospective Study from the ALFA Group
48. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
49. Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies
50. Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.